Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of once-daily application of 1% and 3% HY01 Topical Gel, as assessed
by the change in inflammatory lesion count from baseline over the 12-week treatment period in
patients with moderate-to-severe papulopustular rosacea.